Global Molecular Biology Enzymes, Reagents And Kits Report Thumbnail

Global Molecular Biology Enzymes, Reagents And Kits Market by Application (Sequencing, Restriction Digestion, Cloning) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: NT-73561
  • Author: Up Market Research
  • Rating: 4.6
  • Total Reviews: 94
  • No. Of Pages: 206
  • Format:
  • Pub. Date: 2021-10-21
  • Share:

Summary of the Report

Global molecular biology enzymes reagents and kit market was valued at USD 12.7 million in 2019. It is projected to grow at a compound annual rate (CAGR of 11.0%) between 2020 and 2027. The life sciences research that are used to manage medical conditions have been greatly influenced by technological advances in molecular Biology. This has fueled the demand for molecular science consumables. The market for molecular biological enzymes, kits, and reagents is growing rapidly due to the availability of accurate computational tools, as well as continuous updating biological databases. Systems biology and Omics technology are two of the most prominent emerging concepts in molecular medicine. Researchers can use multi-omics-based technologies such as systems biology, computational power and Bioinformatics to help them better understand disease diversity, disease progression, drug resistance, and molecular heterogeneity in complex pathologies.

The demand for molecular enzymes and reagents is increasing due to omics-based research. Technology and scientific advances have played an important role in shaping product landscapes. This has led to the creation of new guidelines. Common federal agencies such as the Food and Drug Administration and the World Health Organization assess and manage the potential health and environmental risks associated with these products. These factors encourage the use of products under this market for molecular biological enzymes, kits, and reagents.

The emergence of single cell genome sequencing which offers a viable method for accurate assessment of biomolecules including RNA, DNA and chromatin has also accelerated revenue growth. This allows for a better understanding and appreciation of biological diversity by isolating these molecules from one cell. This increases the potential for single-cell sequencing and creates lucrative opportunities to operating companies to profit from the avenues.

The market for molecular biology enzymes, reagents, and kits is driven by constant improvement in the efficiency and specificity of restriction enzymes. These enzymes are crucial in physical mapping DNA across multiple applications, such as DNA fingerprinting or methylation analysis. Research has shown that this enzyme is widely used for the characterization of single cells and for epigenomic and genomic studies. This has subsequently fueled the growth in the market for molecular biological enzymes, reagents, and kits.

Product Insights

With a revenue share in 2019 of 68.5%, kits and reagents dominated molecular biology enzymes and other reagents. The wide range of kits and reagents available and the innovative product development by key companies are two reasons for this success. Asuragen, Inc., introduced the AmplideX PCR/CE SMN1/2 kit in March 2019. This is a reliable and fast method to detect SMN2 or SMN1 exon 7 copies within just 4 hours. It uses a Polymerase Chain Reaction, (PCR), and is intended for molecular diagnostic purposes.

Biotechnology and healthcare companies have been encouraged to produce more RT-PCR-based test kits due to the exponential increase in COVID-19 cases worldwide. According to Thermo Fisher, it plans to produce 5.0 million more COVID-19 tests. The increase in commercially available COVID-19 products is expected to boost the demand for kits, reagents and other COVID-19 diagnostic tools. As a result of the pandemic, Proteinases enzymes have been used in diagnosis.

Cloning technology is now a standard laboratory technology and manufacturers can provide many enzymes to generate and manipulate nucleic acid. The technology has evolved from cloning a single DNA fragment to the assembly multiple DNA fragments into one contiguous DNA stretch. The advancements in cloning technology will have a significant impact on the growth of molecular biology enzymes during the forecast period.

Application Insights

In 2019, the largest revenue share in the molecular biology enzymes reagents kits market was 34.9%. This segment is expected to expand at a rapid pace. The introduction of Next Generation Sequencing (NGS) has made great strides in genetic research and the discovery human diseases. NGS analysis of tumor epigenomics and genomics drives biomarker discoveries for cancer diagnosis and tumor stratification.

NGS offers many benefits, including the detection of the smallest mutation possible, faster combined detection of SNPs and larger abnormalities, as well as the best combination of high-throughput speed and resolution. The demand for sequencing will also increase due to personalized medicine and targeted and whole-exome sequencing. This segment also sees widespread adoption of these technologies, which accelerates the use of molecular biology products.

In 2019, PCR accounted for the second largest revenue share in the market of molecular biology enzymes and reagents. MiniPCR has made it more affordable and portable. On the other hand, the introduction of the droplet digital PCR (ddPCR), which integrates conventional PCR with the fluorescence-activated cell sorting aspects, offers a highly automated and robust technology for the detection of scarce targets in samples. These technological advances are expected to increase revenue in this market.

End-use Insights

In 2019, the largest share of molecular biology enzymes, reagents, and kits sales came from the pharma and biotech segments. This market was dominated by the pharma and the biotech sectors. The demand for molecular biology enzymes is increasing due to an increase in R&D and ongoing clinical trials at pharma and biotech companies. The shift towards personalized medicine and companion diagnostics has prompted collaborations and mergers in the field of sequencing technology. This has subsequently boosted the demand for sequencing products.

QIAGEN, Inc. entered into a 15 year partnership to expand the use of NGS-based, in vitro diagnostic tools for patient management. QIAGEN has the opportunity to create companion diagnostic tests for tumor evaluations in order to be eligible for immunotherapies using the TruSight Oncology Assays from Illumina. These initiatives will also help to drive segment growth at a profitable pace in the market place for molecular biology enzymes and reagents.

NGS and PCR techniques are widely used in academic research projects, which increases the availability of these products at universities and research centres. Researchers at UNC Medical Center Microbiology and Molecular Microbiology Laboratories investigated the use of NGS to accurately diagnose COVID-19, as reported in March 2020. These entities will also be able to attract funding and investment, which is expected to increase the academic and research segments at a significant CAGR.

Regional Insights

North America was the dominant market for molecular biology enzymes and reagents in 2019, accounting for 45.5% of the total revenue. Initiatives such as the Newborn Sequencing in Genomic Medicine and Public Health program of the National Human Genome Research Institute, which screens infants for genetic diseases and boosts the use of NGS technology and its associated kits and reagents, are examples.

Companies based in the U.S. are focusing their efforts on developing technologically advanced products for molecular biological techniques. This will drive the regional market for molecular biotechnology enzymes, kits, and reagents. Crystal Taq, a cost-effective product with higher test accuracy, was launched by Pharmozyme, Inc. in May 2019. This enzyme is free of bacterial and animal DNA contamination, and it reduces background contamination.

The Asia Pacific market for molecular biology enzymes and reagents is expected to grow at a significant rate over the forecast period. The region's growth is influenced by regional players continuing to develop and commercialize point-of-care PCR equipment and other reagents. Fujifilm Wako Pure Chemical Corp., a Japan-based company, began the commercialization in May 2020 of PCR reagents to the automated coronavirus testing device.

Market Share Insights & Key Companies

Many companies, investors, scientific communities, as well as scientists, have been attracted to molecular biology enzymes, kits, and reagents for a variety of applications such as PCR and sequencing. These companies continue to expand their technology portfolios in order to make these products more accessible, affordable, user-friendly, innovative, as well as more accessible. Agilent Technologies launched the Agilent SureSelect XT HS2DNA Kit in January 2020. This kit was created to address the difficulties researchers face when preparing DNA sequencing libraries. Researchers can now choose the workflow that best suits their needs with this new product. This product development will allow the company to speed up its capture-based enrichment library preparation activities. The following are some of the major players in the market for molecular biology enzymes and reagents.

  • Thermo Fisher Scientific, Inc.

  • QIAGEN

  • Illumina, Inc.

  • F. Hoffmann-La Roche Ltd.

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories Inc.

  • New England Biolabs

  • Merck KGaA

  • Promega Corporation

  • Takara Bio, Inc.

  • LGC Limited

Up Market Research published a new report titled “Molecular Biology Enzymes, Reagents And Kits Market research report which is segmented by Application (Sequencing, Restriction Digestion, Cloning), By Players/Companies New England Biolabs, QIAGEN, LGC Limited, Merck KGaA, Takara Bio Inc, F Hoffmann-La Roche Ltd, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Promega Corporation, Illumina Inc, Bio-Rad Laboratories Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report AttributesReport Details
Report TitleMolecular Biology Enzymes, Reagents And Kits Market Research Report
By ApplicationSequencing, Restriction Digestion, Cloning
By CompaniesNew England Biolabs, QIAGEN, LGC Limited, Merck KGaA, Takara Bio Inc, F Hoffmann-La Roche Ltd, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Promega Corporation, Illumina Inc, Bio-Rad Laboratories Inc
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages206
Number of Tables & Figures145
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Molecular Biology Enzymes  Reagents And Kits Industry Outlook

Global Molecular Biology Enzymes, Reagents And Kits Market Report Segments:

The market is segmented by Application (Sequencing, Restriction Digestion, Cloning).

Molecular Biology Enzymes, Reagents And Kits Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Molecular Biology Enzymes, Reagents And Kits Market

Overview of the regional outlook of the Molecular Biology Enzymes, Reagents And Kits Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Molecular Biology Enzymes  Reagents And Kits Market Overview

Highlights of The Molecular Biology Enzymes, Reagents And Kits Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Molecular Biology Enzymes, Reagents And Kits Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
        6. By Application:

                1. Sequencing

                2. Restriction Digestion

                3. Cloning

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Molecular Biology Enzymes, Reagents And Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Molecular Biology Enzymes  Reagents And Kits Market Trends

Reasons to Purchase the Molecular Biology Enzymes, Reagents And Kits Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Molecular Biology Enzymes, Reagents And Kits Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Molecular Biology Enzymes, Reagents And Kits Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Molecular Biology Enzymes, Reagents And Kits Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Molecular Biology Enzymes, Reagents And Kits Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Molecular Biology Enzymes, Reagents And Kits Market Size & Forecast, 2018-2028 
      4.5.1 Molecular Biology Enzymes, Reagents And Kits Market Size and Y-o-Y Growth 
      4.5.2 Molecular Biology Enzymes, Reagents And Kits Market Absolute $ Opportunity 


Chapter 5 Global Molecular Biology Enzymes, Reagents And Kits Market Analysis and Forecast by Application
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Application
      5.1.2 Basis Point Share (BPS) Analysis by Application
      5.1.3 Absolute $ Opportunity Assessment by Application
   5.2 Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Application
      5.2.1 Sequencing
      5.2.2 Restriction Digestion
      5.2.3 Cloning
   5.3 Market Attractiveness Analysis by Application

Chapter 6 Global Molecular Biology Enzymes, Reagents And Kits Market Analysis and Forecast by Region
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Region
      6.1.2 Basis Point Share (BPS) Analysis by Region
      6.1.3 Absolute $ Opportunity Assessment by Region
   6.2 Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Region
      6.2.1 North America
      6.2.2 Europe
      6.2.3 Asia Pacific
      6.2.4 Latin America
      6.2.5 Middle East & Africa (MEA)
   6.3 Market Attractiveness Analysis by Region

Chapter 7 Coronavirus Disease (COVID-19) Impact 
   7.1 Introduction 
   7.2 Current & Future Impact Analysis 
   7.3 Economic Impact Analysis 
   7.4 Government Policies 
   7.5 Investment Scenario

Chapter 8 North America Molecular Biology Enzymes, Reagents And Kits Analysis and Forecast
   8.1 Introduction
   8.2 North America Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Country
      8.2.1 U.S.
      8.2.2 Canada
   8.3 Basis Point Share (BPS) Analysis by Country
   8.4 Absolute $ Opportunity Assessment by Country
   8.5 Market Attractiveness Analysis by Country
   8.6 North America Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Application
      8.6.1 Sequencing
      8.6.2 Restriction Digestion
      8.6.3 Cloning
   8.7 Basis Point Share (BPS) Analysis by Application 
   8.8 Absolute $ Opportunity Assessment by Application 
   8.9 Market Attractiveness Analysis by Application

Chapter 9 Europe Molecular Biology Enzymes, Reagents And Kits Analysis and Forecast
   9.1 Introduction
   9.2 Europe Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Country
      9.2.1 Germany
      9.2.2 France
      9.2.3 Italy
      9.2.4 U.K.
      9.2.5 Spain
      9.2.6 Russia
      9.2.7 Rest of Europe
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 Europe Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Application
      9.6.1 Sequencing
      9.6.2 Restriction Digestion
      9.6.3 Cloning
   9.7 Basis Point Share (BPS) Analysis by Application 
   9.8 Absolute $ Opportunity Assessment by Application 
   9.9 Market Attractiveness Analysis by Application

Chapter 10 Asia Pacific Molecular Biology Enzymes, Reagents And Kits Analysis and Forecast
   10.1 Introduction
   10.2 Asia Pacific Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Country
      10.2.1 China
      10.2.2 Japan
      10.2.3 South Korea
      10.2.4 India
      10.2.5 Australia
      10.2.6 South East Asia (SEA)
      10.2.7 Rest of Asia Pacific (APAC)
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Asia Pacific Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Application
      10.6.1 Sequencing
      10.6.2 Restriction Digestion
      10.6.3 Cloning
   10.7 Basis Point Share (BPS) Analysis by Application 
   10.8 Absolute $ Opportunity Assessment by Application 
   10.9 Market Attractiveness Analysis by Application

Chapter 11 Latin America Molecular Biology Enzymes, Reagents And Kits Analysis and Forecast
   11.1 Introduction
   11.2 Latin America Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Country
      11.2.1 Brazil
      11.2.2 Mexico
      11.2.3 Rest of Latin America (LATAM)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Latin America Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Application
      11.6.1 Sequencing
      11.6.2 Restriction Digestion
      11.6.3 Cloning
   11.7 Basis Point Share (BPS) Analysis by Application 
   11.8 Absolute $ Opportunity Assessment by Application 
   11.9 Market Attractiveness Analysis by Application

Chapter 12 Middle East & Africa (MEA) Molecular Biology Enzymes, Reagents And Kits Analysis and Forecast
   12.1 Introduction
   12.2 Middle East & Africa (MEA) Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Country
      12.2.1 Saudi Arabia
      12.2.2 South Africa
      12.2.3 UAE
      12.2.4 Rest of Middle East & Africa (MEA)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Middle East & Africa (MEA) Molecular Biology Enzymes, Reagents And Kits Market Size Forecast by Application
      12.6.1 Sequencing
      12.6.2 Restriction Digestion
      12.6.3 Cloning
   12.7 Basis Point Share (BPS) Analysis by Application 
   12.8 Absolute $ Opportunity Assessment by Application 
   12.9 Market Attractiveness Analysis by Application

Chapter 13 Competition Landscape 
   13.1 Molecular Biology Enzymes, Reagents And Kits Market: Competitive Dashboard
   13.2 Global Molecular Biology Enzymes, Reagents And Kits Market: Market Share Analysis, 2019
   13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      13.3.1 New England Biolabs
      13.3.2 QIAGEN
      13.3.3 LGC Limited
      13.3.4 Merck KGaA
      13.3.5 Takara Bio Inc
      13.3.6 F Hoffmann-La Roche Ltd
      13.3.7 Agilent Technologies Inc
      13.3.8 Thermo Fisher Scientific Inc
      13.3.9 Promega Corporation
      13.3.10 Illumina Inc
      13.3.11 Bio-Rad Laboratories Inc
Segments Covered in the Report
The global Molecular Biology Enzymes, Reagents And Kits market has been segmented based on

By Application
  • Sequencing
  • Restriction Digestion
  • Cloning
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • New England Biolabs
  • QIAGEN
  • LGC Limited
  • Merck KGaA
  • Takara Bio Inc
  • F Hoffmann-La Roche Ltd
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Promega Corporation
  • Illumina Inc
  • Bio-Rad Laboratories Inc

Buy Report